Cancer Rop Co. Ltd. Cash Flow-to-Debt Ratio
Cancer Rop Co. Ltd. cash flow-to-debt ratio. Cancer Rop Co. Ltd. (180400) has a Cash Flow-to-Debt Ratio of -0.41x as of March 2026, meaning its operating cash flow of ₩-10.04 Billion could theoretically repay 0% of its total liabilities (₩24.60 Billion) in one year. Check 180400 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cancer Rop Co. Ltd. (2014–2025)
Cash flow-to-debt ratio of Cancer Rop Co. Ltd. from 2014 to 2025. Historical debt coverage capacity for Cancer Rop Co. Ltd. across 9 annual periods. Check 180400 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Cancer Rop Co. Ltd. Cash Flow-to-Debt Ratio by Year (2014–2025)
Cancer Rop Co. Ltd. cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Cancer Rop Co. Ltd.. For the full cash flow conversion analysis, see 180400 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.32x | ₩-18.85 Billion | ₩59.11 Billion | ▲ +10.8% |
| 2024 | -0.36x | ₩-20.03 Billion | ₩56.00 Billion | ▼ -110.9% |
| 2023 | -0.17x | ₩-12.06 Billion | ₩71.14 Billion | ▼ -1110.8% |
| 2022 | 0.02x | ₩865.55 Million | ₩51.60 Billion | ▲ +111.1% |
| 2018 | -0.15x | ₩-4.94 Billion | ₩32.64 Billion | ▼ -59.4% |
| 2017 | -0.09x | ₩-2.14 Billion | ₩22.49 Billion | ▲ +95.9% |
| 2016 | -2.33x | ₩-1.50 Billion | ₩644.52 Million | ▼ -70.5% |
| 2015 | -1.37x | ₩-841.17 Million | ₩614.80 Million | ▼ -191.3% |
| 2014 | 1.50x | ₩783.83 Million | ₩522.87 Million | — |